This article with the most representative slides to start the roadshow, will allow us to face with guarantees the success of the journey we will undertake in the negotiation of our investment round wi...
Read moreResearchers from the Bellvitge Biomedical Research Institute (IDIBELL), the Sant Joan de Déu Research Institute (IRSJD), and the UB have presented a new model based on human stem cells of an ultra...
Read moreLa investigación del Cancer Center Clínica Universidad de Navarra pretende desarrollar en el Cima nuevas herramientas traslacionales que permitan un mejor diseño de ensayos de inmunoterapia.
Read moreEl Instituto de Investigación del Hospital de la Santa Creu i Sant Pau – IIB Sant Pau ha desarrollado un nuevo medicamento de inmunoterapia CAR-T que acaba de empezar a administrar, en el marco de ...
Read moreMinoryx Therapeutics today announces the US Food and Drug Administration (FDA) approval of its Phase 3 clinical trial (CALYX) of lead candidate leriglitazone, to treat adult male X-linked Adrenoleukod...
Read moreEsta inversión marca el inicio de una nueva etapa para la compañía, con nuevos retos y desafíos, y acompaña en el camino para conseguir el objetivo; mejorar el diagnóstico en ginecología convir...
Read moreGENESIS Tech Transfer Boost, an investment vehicle created in 2022 and managed by the consultancy firm GENESIS Biomed, has made its first investment for a ticket of €25,000 in the biotech company Sp...
Read moreLa financiación levantada por las empresas que forman parte de la Comunidad PCB, en operaciones identificadas en el ejercicio 2022, alcanzó los 142M€, un récord absoluto, de los que 83M€ (un 58...
Read moreCorWave raised 61 million euros to fund its first industrial deployment and entry into clinical trials. SPI fund, managed by Bpifrance on behalf of the French Government as part of France 2030, and le...
Read moreOncoDNA, a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases, today announced the closing of a Round C financing of 6,5 ...
Read moreResearchers from VHIO's Experimental Hematology Group have participated in the development of a new technology to manufacture CAR-T cells or genetically modified lymphocytes to attack tumor cells, whi...
Read moreTop Doctors, grupo tecnológico líder en la transformación digital del sector sanitario y el fácil acceso a los mejores especialistas médicos, ha anunciado la adquisición de la británica I Want ...
Read more